Cuaj-Canadian Urological Association Journal最新文献_第10页

Resident assessment in urology: ChatGPT, take the wheel? 泌尿外科住院医师评估：ChatGPT，拿方向盘？

IF 1.9 4区医学

Cuaj-Canadian Urological Association Journal Pub Date : 2025-06-01 DOI: 10.5489/cuaj.9256

Naji J Touma

引用次数: 0

Poster Session 4: Functional Urology (Part 1) Saturday, June 28, 2025 • 16:00-17:30. 2025年6月28日（周六）16:00-17:30。

IF 1.9 4区医学

Cuaj-Canadian Urological Association Journal Pub Date : 2025-06-01 DOI: 10.5489/cuaj.9261

引用次数: 0

Poster Session 10: Health Equity, Basic Science, New Technology Sunday, June 29, 2025 • 07:00-08:30. 2025年6月29日（星期日）07:00-08:30

IF 1.9 4区医学

Cuaj-Canadian Urological Association Journal Pub Date : 2025-06-01 DOI: 10.5489/cuaj.9268

引用次数: 0

Association of absolute amount of pattern 4 disease on prostate biopsy with oncologic outcomes in intermediate-risk prostate cancer A systematic review. 前列腺活检第 4 型疾病的绝对数量与中危前列腺癌的肿瘤学预后的关系：系统综述。

IF 1.9 4区医学

Cuaj-Canadian Urological Association Journal Pub Date : 2025-06-01 DOI: 10.5489/cuaj.8995

Melissa Sam Soon, Scott C Morgan, Luke T Lavallée, Rodney H Breau, Trevor A Flood, Mark T Corkum

{"title":"Association of absolute amount of pattern 4 disease on prostate biopsy with oncologic outcomes in intermediate-risk prostate cancer A systematic review.","authors":"Melissa Sam Soon, Scott C Morgan, Luke T Lavallée, Rodney H Breau, Trevor A Flood, Mark T Corkum","doi":"10.5489/cuaj.8995","DOIUrl":"10.5489/cuaj.8995","url":null,"abstract":"Introduction: Managing intermediate-risk prostate cancer is challenging due to the heterogeneity in patient outcomes within this risk category. Evaluating the absolute amount of Gleason pattern 4 disease (GP4) at biopsy using the total linear length of pattern 4 (GP4-TL) or absolute percentage of pattern 4 (APP4) may enhance risk stratification. This review aimed to determine if these absolute measures predict oncologic outcomes in IRPC and to identify optimal prognostic thresholds.Methods: A systematic review was conducted following PRISMA guidelines. Studies included were those reporting the absolute amount of GP4 on biopsy and related outcomes in IRPC patients undergoing surgery or radiotherapy. Outcomes included biochemical recurrence, androgen deprivation therapy (ADT)-free survival, distant metastasis, prostate cancer-specific mortality, all-cause mortality, and adverse pathology.Results: Seven studies with a total of 2523 patients were included. Analysis revealed that APP4 thresholds were highly predictive of biochemical recurrence, ADT-free survival, and distant metastasis. Both APP4 and GP4-TL were superior to relative % GP4 and Gleason grading (4+3 vs. 3+4) in predicting disease progression and mortality.Conclusions: The absolute amount of GP4 shows consistent associations with important clinical outcomes and offers an accessible and established method to enhance risk stratification. Further research is needed to define optimal thresholds to guide treatment decisions.","PeriodicalId":50613,"journal":{"name":"Cuaj-Canadian Urological Association Journal","volume":" ","pages":"211-216"},"PeriodicalIF":1.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12158451/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Poster Session 7: Oncology-Prostate (Part 2) Sunday, June 29, 2025 • 07:00-08:30. 2025年6月29日（星期日）07:00-08:30。

IF 1.9 4区医学

Cuaj-Canadian Urological Association Journal Pub Date : 2025-06-01 DOI: 10.5489/cuaj.9264

引用次数: 0

The arc of the guideline universe is long, but it bends toward GRADE. 指导范围的弧线很长，但它向GRADE方向弯曲。

IF 1.9 4区医学

Cuaj-Canadian Urological Association Journal Pub Date : 2025-06-01 DOI: 10.5489/cuaj.9247

Rodney H Breau

引用次数: 0

Assessing complications from retroperitoneal lymph node dissection for testicular cancer in North America. 评估北美洲睾丸癌腹膜后淋巴结清扫的并发症。

IF 1.9 4区医学

Cuaj-Canadian Urological Association Journal Pub Date : 2025-06-01 DOI: 10.5489/cuaj.9042

Mithun Kailavasan, Jose de Jesus Cendejas-Gomez, Melissa J Huynh, Brant A Inman, Nicholas Power

{"title":"Assessing complications from retroperitoneal lymph node dissection for testicular cancer in North America.","authors":"Mithun Kailavasan, Jose de Jesus Cendejas-Gomez, Melissa J Huynh, Brant A Inman, Nicholas Power","doi":"10.5489/cuaj.9042","DOIUrl":"10.5489/cuaj.9042","url":null,"abstract":"Introduction: Retroperitoneal lymph node dissection (RPLND) is a procedure of significant therapeutic and diagnostic value in the management of testicular cancer. This study aimed to conduct a contemporary review of surgical outcomes following RPLND procedures performed in North America over the last decade.Methods: We queried the National Surgical Quality Improvement Program (NSQIP) database from 2012-2022 (n=9 857 040) to identify patients who underwent RPLND and were diagnosed with testicular cancer. The primary outcome was 30-day morbidity. Secondary outcomes included time-to-complication analysis, rate of additional organ resection, hospital length of stay (LOS), and readmission rates. Binomial logistic regression and a generalized linear model were used to identify risk factors associated with 30-day morbidity and LOS.Results: A total of 513 RPLND procedures met the inclusion criteria. The median age was 30 years (interquartile range [IQR] 24-36.50) with a body mass index of 27.9 kg/m2 (IQR 24.5-32.0). There were no deaths within 30 days. The overall 30-day morbidity rate was 17% (n=86). Bleeding/transfusion postoperatively (12%), return to the operating room (3%), and superficial surgical-site infection (2%) were the three most common complications. Factors associated with increased 30-day morbidity included: history of smoking (odds ratio [OR] 2.5, 95% confidence interval [CI] 1.35-4.68) and concurrent vascular repair/reconstruction (OR 4.1, 95% CI 1.12-15.46). The median LOS was four days (IQR 3-6) and the 30-day readmission rate was 7.0%.Conclusions: This study underscores that approximately one in six patients experience complications following RPLND in North America. Identifying the timing of and risk factors for these complications can improve physician-patient communication and overall care.","PeriodicalId":50613,"journal":{"name":"Cuaj-Canadian Urological Association Journal","volume":" ","pages":"167-172"},"PeriodicalIF":1.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12158452/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Poster Session 12: Andrology Sunday, June 29, 2025 • 07:00-08:30. 2025年6月29日，周日，07:00-08:30。

IF 1.9 4区医学

Cuaj-Canadian Urological Association Journal Pub Date : 2025-06-01 DOI: 10.5489/cuaj.9270

引用次数: 0

Poster Session 3: Oncology-Bladder Saturday, June 28, 2025 • 16:00-17:30. 2025年6月28日（周六）16:00-17:30。

IF 1.9 4区医学

Cuaj-Canadian Urological Association Journal Pub Date : 2025-06-01 DOI: 10.5489/cuaj.9260

引用次数: 0

Poster Session 6: Transplant, Training/Education Saturday, June 28, 2025 • 16:00-17:30. 海报展区6：移植、培训/教育2025年6月28日（周六）16:00-17:30

IF 1.9 4区医学

Cuaj-Canadian Urological Association Journal Pub Date : 2025-06-01 DOI: 10.5489/cuaj.9263

引用次数: 0